ERBB2 and neoplasm: As suggested in Table 3, SUVmax was higher in HER2-positive tumor, thus it seems reasonable that luminal B tumors with high SUVmax (Group 4) had a higher HER2-positive rate than luminal B tumors with low SUVmax (Group 2).